HCPCS Level IIdrugActive
J8501
Oral aprepitant
BETOS: O1E
Effective: 2019-01-01
Referenced in 1 policies
Description
Aprepitant, oral, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Emend
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
5 MG
Billing Units
16.0000
21
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.